可定对阿司匹林抗血小板功能干预.docVIP

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
可定对阿司匹林抗血小板功能干预

可定对阿司匹林抗血小板功能干预[摘要] 目的 探讨小剂量阿司匹林对原发性高血压患者血小板生化指标的影响及可定的干预作用。方法 将121例原发性高血压患者随机分为阿司匹林组和可定组,阿司匹林组持续服用阿司匹林、可定组在服用阿司匹林1周后加服可定,两组在服药1周及4周后,分别检测用二磷酸腺苷(ADP)和花生四烯酸(AA)作诱导剂的血小板聚集率(PAG)、血浆P-选择素和血栓素B2(TXB2)浓度。结果 1周后血浆P-选择素、TXB2浓度与AA和ADP诱导的PAG均呈正相关;血浆P-选择素浓度与TXB2浓度也呈正相关;两组间三项指标比较差异无统计学意义。4周后两组AA和ADP诱导的PAG、血浆P-选择素和TXB2浓度均显著低于1周后的检测值(P<0.01);可定组上述指标均显著低于阿司匹林组(P<0.05);两组不良反应发生率差异无统计学意义(P>0.05)。结论 可定能增强阿司匹林对原发性高血压患者的抗血小板疗效,且不增加不良反应 [关键词] 原发性高血压;可定;阿司匹林;血小板生化指标 [中图分类号] R96 [文献标识码] B [文章编号] 1673-9701(2011)33-55-02 Intervening Effect of Rosuvastatin on Antiplatelet Treatment with Aspirin HONG Chenglv CHEN Dakai ZHANG Huaiqin Department of Cardiovascular Disease,the First Affiliated Hospital of Wenzhou Medical College,Wenzhou 325000,China [Abstract] Objective To explore the effect of small dosage aspirin on platelet biochemical indexes in patients with primary hypertention diseases and the intervening action of Rosuvastatin. Methods The 121 cases were assigned to the aspirin group and the Rosuvastatin group. Both group took aspirin for four weeks,but to patients in the Rosuvastatin group,they were given rosuvastatin for three weeks. Then the blood levels of P-selectin,TXB2 and PAG induced by AA and ADP were detected twice after both groups were medicated for one week and four weeks. Results The first determination showed the concentration of p-selectin and TXB2 were positively correlated with PAG,either induced byAA or by ADP. Positive correlation also showed between plasma level of P-selectin and TXB2. There was no significant difference of three indexes between two groups(P>0.05). Reexamination showed that levels of the 3 indexes significantly decreased in both groups(P<0.01),and all were lower in the Rosuvastatingroup than in the aspirin group respectively(P<0.05).There was no difference inthe incidence of adverse reaction between two groups(P>0.05). Conclusion Rosuvastatin could enhance antiplatelet effect of aspirin for patients with primary hypertension without i

文档评论(0)

docman126 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:7042123103000003

1亿VIP精品文档

相关文档